CURRICULUM VITAE Eric J. Lenze, M.D. - Institute for Public Health

70. Mohlman J, Bryant C, Lenze EJ, Stanley MA, Gum A, Flint A, Beekman AT, Wetherell JL, Thorp
SR, Craske MG (2012): Improving recognition of late life anxiety disorders in DSM-V:
Observations and recommendations of the Advisory Committee to the Lifespan Disorders Work
Group. International Journal of Geriatric Psychiatry 27: 549-556.
71. Lenze EJ, Skidmore ER, Begley AE, Newcomer J, Butters MA, Whyte EM (2011): Memantine
for late-life depression and apathy after a disabling medical event: a double-blind, placebocontrolled,
12-week pilot study. International Journal of Geriatric Psychiatry 27(9):974-980.
72. Hildebrand MW, Host HH, Binder EF, Carpenter B, Freedland KE, Morrow-Howell N, Baum CM,
Dore P, Lenze EJ (2012): Measuring treatment fidelity in a rehabilitation intervention study.
American Journal of Physical Medicine and Rehabilitation 91(8):715-24.
73. Lenze EJ (2012): Reversal of SSRI-associated urinary retention with mirtazapine augmentation
(letter). Journal of Clinical Psychopharmacology; 32(3): 434.
74. Lenze EJ, Dixon D, Nowotny P, Lotrich FE, Dore P, Pollock BG, Hinrichs AL, Butters MA
(2013): Escitalopram reduces attentional performance in anxious older adults with highexpression
genetic variants at serotonin 2A and 1B receptors. International Journal of
Neuropsychopharmacology 16(2): 279-288.
75. Sylvester C, Corbetta M, Raichle M, Rodebaugh TL, Sheline YI, Schlagger B, Zorumski C,
Lenze EJ (2012): Functional network dysfunction in anxiety and anxiety disorders. Trends in
Neurosciences 35: 527-535. PMCID: PMC3432139
76. Lenze EJ, Host HH, Hildebrand MW, Morrow-Howell N, Carpenter B, Freeland KE, Baum CA,
Dixon D, Dore P, Wendleton L, Binder EF (2012): Enhanced Medical Rehabilitation increases
therapy intensity and engagement and improves functional outcomes in post-acute rehabilitation
of older adults: a randomized controlled trial. Journal of the American Medical Director’s
Association 13(8): 708-712.
77. Rodebaugh TL, Levinson CA, Lenze EJ (2013): A high-throughput clinical assay for testing drug
facilitation of exposure therapy. Depression and Anxiety (epub).
78. Shea MO, Garfield L, Teitelbaum S, Civitelli R, Dixon D, Mulsant BH, Reynolds CF, Lenze EJ
(2013): Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated
with increased marker of bone resorption. Osteoporosis International (epub).
79. Rosnick C, Butters MA, Rawson K, Lenze EJ (2013): Association of cortisol with
neuropsychological assessment in older adults with Generalized Anxiety Disorder. Aging and
Mental Health (epub).
80. Joel I, Begley AE, Mulsant BH, Lenze EJ, Mazumdar S, Dew MA, Blumberger D, Butters MA,
Reynolds CF: Dynamic prediction of treatment response in late-life depression. American
Journal of Geriatric Psychiatry in press.
81. Wetherell JL, Petkus AJ, White KS, Nguyen H, Kornblith S, Andreescu C, Zisook S, Lenze EJ:
Antidepressant medication augmented with cognitive behavioral therapy for Generalized Anxiety
Disorder in older adults. American Journal of Psychiatry in press.
Peer-Reviewed Invited Papers:
1. Lenze EJ, Mulsant BH, Shear MK, Houck P, Reynolds CF (2002): Anxiety symptoms in elderly
patients with depression: what is the best approach to treatment? Drugs and Aging 19(10):753-
60.
2. Lenze EJ, Shear MK, Mulsant BH, Reynolds CF (2002): Anxiety disorders in late life: an
evolving picture. CNS Spectrums 7(11): 805-810.
3. Lenze EJ (2003): Comorbidity of depression and anxiety in the elderly. Current Psychiatry
Reports 5(1): 62-67.
20